Connection

Jordan Elm to Hematoma

This is a "connection" page, showing publications Jordan Elm has written about Hematoma.
Connection Strength

0.048
  1. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. Int J Stroke. 2022 08; 17(7):806-809.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.